Introduction cular syndromes such as myocardial infarction and limb ischemia in which urinary albumin changes parIncreased urinary albumin excretion ( UAE ) in the alleled neutrophil activation at the time of exercisemicroalbuminuric range (i.e. in amounts not detectable induced pain in arteriopaths or exaggerated vascular by the usual dipstick methods for urine protein) characalbumin permeability after rat hindlimb ligation [4 ] . terizes a sub-sample of non diabetic essential hypertensIn these 'acute phase' conditions, inflammatory ives subjects, probably ranging between 10-20% of the mediators are likely released in blood and may increase overall hypertensive population [1] . Since the abnormicrovascular permeability by damaging vascular mality is associated with an augmented frequency of endothelium, a prime target for any substance reaching atherosclerotic cardiovascular complications independthe circulation. Altered glomerular permeability as a ently from the association with classical risk factors, part of a systemic endothelial dysfunction and/or injury microalbuminuria may represent an autonomous could, therefore, explain the appearance of microalbumarker of vascular damage [1 ] . The hypothesis minuria in absence of any evidence of functional or postulates that an increased UAE reflects the abnormal structural renal impairment. This possibility is also systemic trans-vascular macromolecular leakage in suggested by the behaviour in both the early phases of atherogenesis, where permeability changes occur since myocardial infarction and surgery of von Willebrand the earliest stage [2 ] as a consequence of damaged Factor (vWF ) levels, an endothelial-derived hemostatic vascular endothelium, a structure intimately involved factor produced in greater quantity by a dysfunctional in vascular permeability as well as haemostasis, fibendothelium, and elevated in frank atherosclerotic rinolysis and vasomotion [3 ] . This paper will briefly vascular disease, in presence of all major risk factors review the still limited available evidence, either direct, of atherosclerosis including diabetes and hypertension, inferential or circumstantial, which supports this and in most of the inflammatory vasculitides [5 ] . possibility with particular regard to recent work in Similar interpretation may be given to the report of hypertension, taking advantage also of data obtained microalbuminuria in patients with systemic sclerosis, in apparently unrelated clinical conditions which may a syndrome characterized by excessive collagen synhelp to make the point. One should be aware, however, thesis, increased vascular permeability and endothelial that several other biological factors, primarily blood damage caused by widespread vascular damage [1 ] . pressure levels, may per se influence the levels of Whether UAE behaves similarly in other vasculitides albuminuria in hypertensive patients [1 ] . Due to the is, however, still unsettled. constraint of the editorial format, quotations will be generally limited to reviews in which the reader may find the specific references.
marker of endothelial dysfunction, are frequently unjustified, especially in pathological states [1 ] .
Unpredictable dependence upon endogenous muscarfound in microalbuminuric diabetics [8 ] and blunted vasoconstriction to regional nitric oxide synthesis inic receptor reserve, wide interindividual variability in acetylcholine esterase activity, difficulties in transferinhibition was shown in microalbuminuric type I diabetics compared with both control subjects and patients ring results obtained in a single regional bed to the whole vascular system, discordance with the biological without incipient nephropathy [1 ] . Therefore, one might deduct that endothelial dysfunction may, at least actions of other endothelial active vasodilators and lack of knowledge about the long-term prognostic in part, contribute to microvascular permeability not only in acute inflammatory conditions but even in a cardiovascular implications constitute additional problems of the technique. A next not fully addressed chronic disease state such as diabetes. This assumption, however, is speculative because a direct link between question is also whether results obtained through the acetylcholine infusion can be extrapolated to those the degree of endothelial dysfunction and of transvascular molecular leakage has never been shown. Besides, obtained by vWF determination. As a matter of fact, within-subject comparison of forearm acetylcholine the relative importance of endothelial vs postendothelial mechanisms as determinants of the transcapillary responsiveness and von Willebrand Factor suggests that the two different endothelial markers do not reflect escape rate is still unclear [6 ] . Whatever the case, the association between UAE and systemic microvascular the same underlying alteration [12] .
A second line of evidence suggesting a link between permeability is not restricted to diabetes since similar data were reported in apparently healthy subjects, microalbuminuria and systemic vascular status in hypertension is based upon the finding of elevated and smokers in whom both microalbuminuria and endothelial damage are frequent [1] .
UAE in a sample of well characterized essential hypertensives with atherosclerotic peripheral vascular disease as compared with either uncomplicated hypertensives Hypertension or normal controls [13 ] . Thus, urine albumin levels may reflect widespread atherosclerosis, a possibility supported also by the positive correlation with ultraBeside the epidemiological data of an independent association of microalbuminuria with vascular events sonographic carotid thickness, a surrogate quantitative measure of the systemic atherosclerotic process [13 ] . [1 ] , other lines of evidence suggest a link between microalbuminuria and systemic vascular status in The hypothesis is strengthened by the correlation between UAE and circulating vascular cell adhesion hypertension. One of them is based upon the evaluation of biochemical markers of endothelial dysfunction molecule-1 (sVCAM-1 ), a protein expressed on the surface of activated endothelial cells, and expressed in and/or damage, mainly vWF, a hemostatic endothelialderived factor [5] whose levels were found elevated early atherosclerosis [14 ] . Since part of the protein is shed in the circulation and can be detected in peripheral only in apparently uncomplicated [9] and elderly microalbuminuric hypertensives [10] as compared with plasma, sVCAM-1 may be a circulating marker of the presence and severity of atherosclerosis in humans. non albuminuric patients, confirming that-as it is now becoming evident in spite of contrary statements, Even in this sample of patients, systolic BP-as frequently documented-was a strong predictor of UAE endothelial dysfunction is not universal in hypertensive patients [3] . Endothelial dysfunction in microalbumin- [13] , a result that may not only represent the influence of purely hydraulic factors. In fact, systolic hyperuric essential hypertensives is also suggested by the missing renal vasodilatation in response to -arginine, tension emerges more and more as a marker of atherosclerotic risk, possibly because reduced aortic the physiological precursor of endogenous nitric oxide ( A. Mimran, personal communication), a finding in compliance due to vessel wall stiffening is often seen in association with aortic atherosclerosis which, in contrast with the preserved response to acetylcholine, a drug which stimulates release of that substance, in turn, reflects general atherosclerosis and predicts symptomatic cardiovascular disease [15 ] . the forearm of patients with elevated UAE [11 ] . The data may reflect a heterogeneous degree of endothelial
In conclusion, microalbuminuria might be seen as an integrated marker of risk because of its relationships dysfunction among regional beds, but also the inherent limits of acetylcholine as a biological test to evaluate with the major predictors of cardiovascular mortality and morbidity in hypertensive patients. However, UAE endogenous endothelial function. First of all, the response to muscarinic agonists does not necessarily as such, may also mirror a diffusely altered vascular permeability and endothelial damage; whether this is reflect the underlying tonic activity of this biological system. For example, comparable vasodilator responses the reason which contributed independently to the greater morbidity and mortality in microalbuminuric to muscarinic stimulation were obtained in insulin dependent microalbuminuric patients in whom the subjects is still unsettled. response to -NMMA, an antagonist of the endogenous nitric oxide system, was defective [1 ] One approach employed by historians to highlight the engages prostaglandin release and the nitric oxide unanticipated involves asking a rhetorical question: pathway. Much of the energy invested to this point on What might have been expected, reasonably, on a mechanisms has reflected this fact, and a strong suspicertain date? In 1972, when ACE inhibition was first cion held by many that the kinin pathway makes a emerging, surely no one would have guessed that 25 very substantial contribution to the therapeutic efficacy years later the ACE inhibition story would involve as of ACE inhibition. Should that be the case, alternatives many therapeutic triumphs as it has. Difficult hyperten-for blocking the renin system via renin inhibition or sion requiring three or more drugs for hypertension competitive Ang II antagonists would have limited control was identified early as a reasonable target, therapeutic application. followed by scleroderma renal crisis, congestive heart Another view is possible. No pharmacologist examfailure, myocardial remodelling after myocardial ining the renin cascade would have chosen to block infarction, diabetic nephropathy, and in all likelihood, the ACE step. The first step -the renin:angiotenother forms of progressive renal injury. Current interest sinogen interaction-is rate limiting, and remarkably in the specific underlying pharmacological mechanisms specific, which would have made it a much more by which ACE inhibition achieved its goal reflects not attractive alternative. The AII receptor provides a only the pleasure that we all share in understanding a second attractive target. Because Ang II formation can process, but also a more specific and more practical be catalyzed by a number of serine poteases, and they issue. With the birth of alternatives to ACE inhibition are ubiquitous, pharmacological interruption at the for blocking the renin system, we have a new choice Ang II receptor level has the distinct potential advantand an unambiguous need to understand the mechan-age of blocking the action of Ang II, whatever the isms. The fact that we call the responsible enzyme pathway of its formation. The fact that ACE inhibition 'ACE' reflects our narrow, provincial view. The enzyme came along before the two alternatives was not a is a peptidyl dipeptide hydrolase and has a wide range product of a planned program, but rather was an of substrates, among them bradykinin, and thus unanticipated byproduct of snake toxin pharmacology.
This was a happy accident, but an accident nonetheless. cological interruption of the renin system. However, the AT1 receptor opens the short feedback loop, thereby leading to renin release and increased Ang II because of limited bioavailability of the agents developed, costs, and the rapid development of a formation. With the AT1 receptor blocked, this sequence could lead to unopposed activation of the pharmacological alternative -the Ang II antagonist class-attempts to develop renin inhibitors for clinical AT2 receptor-with unknown but potentially negative consequences. All of these considerations favor ACE application appear to have ceased. The Ang II antagonists, on the other hand, have gained substantial inhibition over Ang II AT1 antagonist action-but it is crucial to remember that each is a construct, an idea momentum. Several dozen AT1 receptor antagonists were developed by several dozen pharmaceutical firms based on a slim database, generally obtained in vitro.
Perhaps the most important consideration in and, at the moment these words are being written, two are marketed in Western Europe or the USA, and at Ichikawa's analysis involved glomerular hemodynamics, especially glomerular capillary pressure, which for least another 11 agents are under active clinical investigation [1] . During these agents' development, there many goes beyond the construct level. In brief, this analysis suggests that much of the ACE inhibitor have been several focuses of interest beyond blood pressure reduction. dependent improvement in natural history reflects the salutary effect of ACE inhibition on glomerular capilThe first involved directly the possibility that the lack of specificity of ACE, and thus of ACE inhibition lary pressure via bradykinin-mediated efferent arteriolar dilatation. Thus, the kininase action of ACE contributed to one of its more annoying and disruptive side effects, cough. One widely held concept was that inhibitors is crucial, and the reduction in Ang II formation is less important-or even irrelevant. cough reflected bradykinin accumulation or accumulation of other cough-promoting factors such as subOnly a solid therapeutic trial in humans can resolve this issue. Should this apparently compelling argument stance P [2] . A study designed to address this issue found that the incidence of cough in losartan-treated lead us to dissuade the decision makers from committing to such studies? There are two reasons for going patients was essentially identical to cough in thiazidetreated patients: As the patient population was selected ahead. First, one can make an equally compelling argument for potential efficacy of Ang II antagonists, for study not only because they were believed to have suffered from ACE-inhibitor induced cough, but also based on more effective blockade of the renin system. Second, much of the most important data reviewed showed cough on rechallenge with an ACE inhibitor, the finding was especially persuasive [3 ] . The AT1 above were obtained in vitro or in small animal models.
If studies in rats never predicted responses in humans, receptor antagonists had passed their first important test beyond blood pressure efficacy, with this success-we would probably ever do studies in rats -or at least would not read them. If studies in rats always predicted ful study.
There has been far more interest in the kidney, and what would happen in humans, we could not justify studies in humans. Is this an area in which there might the possibility that AT1 receptor antagonists will prevent nephropathy, than at the same stage in the be important species differences?
I addressed that issue specifically in a recent editorial evolution of ACE inhibitor therapy [4 ] . There are a number of reasons. Although end-stage renal disease on ACE inhibition and the kidney [6 ] . To isolate species differences one has to apply an essentially ( ESRD) is far less common than acute myocardial infarction and other cardiovascular endpoints, it is identical protocol to multiple species. Bradykinin antagonists blunted the renal vasodilator response to ACE enormously costly. Identification of stages, especially the earliest stages, is relatively easy, as is assessment inhibitors in the dog and in the rat, but not in the rabbit. In accord, an Ang II antagonist blunted someof progression. All make renal injury an attractive therapeutic target with implications that may go well what ACE inhibitor induced renal vasodilation in the rat and dog, but blocked it completely in the rabbit. beyond the specifics of ESRD prevention. For these reasons many of our colleagues have urged the pharma-ACE inhibition increased prostaglandin release in rat and canine kidneys, but not that of the rabbit. In an ceutical firms involved in AT1 receptor antagonist development to pursue studies on the kidney, and elegant study Roman, et al. showed that in the rat it was medullary perfusion that was primarily kinin many of these companies have shown interest. All have had to address an issue raised in the title of a recent dependent [7 ] . Thus, apparent species differences may be primarily anatomical, reflecting the relative contrireview by Ilkuni Ichikawa, who has made substantial contribution to this field [5] . 'Will Ang II receptor-bution of medullary perfusion to total renal blood flow: In this feature humans resemble the rabbit far antagonist be renoprotective in humans?' His essay reflects a substantial body of current thinking. more than they do the rat or dog [6 ] . Whatever the explanation one clear message emerges: We cannot Ichikawa based his analysis on a range of considerations, the majority of which seem to favor ACE extrapolate from studies in a limited range of species, especially the rat, to control mechanisms in humans, inhibition as these considerations suggest that angiotensin is not involved [5 ] . ACE inhibitors can influence even in health and much less so when disease is superimposed. alternative pathways that might, in turn, influence extracellular matrix protein degradation and the rate What of information on the control of the renal circulation in humans, and the mechanisms by which of development of glomerulosclerosis. Macrophage infiltration is also ACE inhibitor responsive. Blocking ACE inhibition might influence the renal circulation?
Although there are powerful limitations in the studies performed with an identical model, protocol and technique. Two Ang II antagonists induced a approach that can be employed in humans, several renovasodilator response that matched, or exceeded lines of evidence provide an answer. The striking slightly the response to renin inhibition in healthy influence of salt intake on the renal vasodilator humans on a low salt diet [8, 9] . From this observation response to ACE inhibition was recognized early, and we would draw several conclusions. The renal haemosupports a dominant role for the Ang II mechanism. dynamic response to ACE inhibition has underestiThis observation is necessary but is not sufficient. More mated, systematically, the contribution of Ang II to recently, comparative pharmacology has strengthened renovascular tone. The effectiveness of renin inhibition that conclusion substantially. If the renal vasodilatsuggests that this response represents interruption of ation induced by ACE inhibitors in humans included primarily renin-dependent, additional non-ACEa substantial component due to bradykinin, prostadependent pathways. In healthy humans, there might glandins, or nitric oxide, one would anticipate that the be a small contribution from proteolytic pathways that renovasodilator response to a renin inhibitors would bypass both renin and ACE. In disease, on the other be substantially less. To our surprise the renal vasodilhand, the latter pathway may provide a more substanator response to a renin inhibitor, enalkiren, exceeded tial contribution [9] . expectations from early experience with ACE inhibitors The final conclusion is that therapeutic trials with [6 ] . To address this issue, we performed a range of Ang II antagonists offer far more promise than did follow-up studies. To ascertain whether the observation ACE inhibitors, despite the gloomy predictions. They represented an idiosyncracy of one renin inhibitor, we are more effective blockers. studied a second-with an identical result. Because of the notorious risk of employing historic controls, we performed a study in which patients received an ACE References inhibitor, a renin inhibitor, or vehicle during the The presence of a volume dependent circulating Na-K-plasma. It inhibited 86Rb uptake of human red cells ATPase inhibitor was first demonstrated in animals and isolated Na-K-ATPase and competed with 3H [1 ] . Subsequently the finding that ouabain sensitive ouabain for binding onto Na-K-ATPase. Mass spectrosodium transport of leucocytes from normotensive metry showed that this human substance had spectra subjects is depressed by incubation in the plasma of identical to those of plant ouabain. Using an antibody hypertensive patients suggested that the circulating raised against plant ouabain it was found that substance responsible might be involved in essential normal human plasma has a mean concentration of hypertension. It was proposed that a renal defect in 138±43 pmol/l, and it was claimed that endogenous sodium excretion was the cause of the increase in the ouabain originates from the adrenal. plasma concentration of the Na-K-ATPase inhibitor
There was an initial uncertainty that perhaps plant and that the resultant increase in intracellular sodium ouabain was an exogenous contaminant. A number of and calcium enhanced vascular reactivity and elevated dietary compounds including tea and rat chow contain the blood pressure [2 ] . Initially it was also thought sodium pump inhibitors. Another difficulty was that that the inhibitor might inhibit tubular sodium reab-while ouabain has a cis junction (CD cis) a biosynthetic sorption and be natriuretic. Later there was a belated pathway for CD cis steroids in humans has not yet recognition that there was little evidence to support been described. It was also pointed out that the glycosthe widely held view that Na-K-ATPase inhibitors are ide of plant ouabain -rhamnose is not normally natriuretic for the natriuretic effect of ouabain or associated with mammals. The principal problem in digoxin, in a normal animal, is negligible unless injected accepting the discovery of plant ouabain in human directly into the renal artery in toxic amounts. plasma was the failure by some workers to reproduce There was then a search for a circulating Na-K-the earlier results with antibodies raised against plant ATPase inhibitor which might be involved in hyperten-ouabain, particularly if they used a HPLC step in the sion whether or not it also had natriuretic properties. preparation of the plasma extract for this made it The search was encouraged by the fact that evolution possible to compare the elution fraction of commercial has endowed all animals with highly specific ouabain plant ouabain with that of the immunoreactive fracbinding sites and a circulating ouabain-like substance tions in the extract [6 ] . Using this step plant ouabain seemed to mirror the relatively recent finding of has either not been found in the plasma or it has been endorphins as ligands for the opiate receptors. present in much smaller quantities than of other substances which bind onto plant ouabain antibodies. Similarly two groups reported that the plasma level of
Plasma ouabain
immunoreactivity to antibodies raised against plant ouabain is unchanged by adrenalectomy. The most Hamlyn and Blaustein [3 ] found a significant correla-divergent finding was that though the plasma level of tion between the mean arterial pressure and the capa-immunoreactivity to plant ouabain antibodies in the city of deproteinized boiled plasma to inhibit dog spontaneously hypertensive rat (SHR) was greater kidney Na-K-ATPase. Goto and colleagues measured than in its normotensive control the WKY rat the the capacity of plant ouabain to bind to cultured amount of true plant ouabain as authenticated by canine renal cells before and after they were incubated HPLC was less in the SHR than in the WKY. It was in plasma [4 ] . The plasma of hypertensive patients the level of immunoreactive substances to plant ouadepressed ouabain binding by~30% and there was a bain antibodies other than plant ouabain which was correlation between systolic pressure and the extent of raised in the SHR. It seemed that the various antibodies ouabain binding. Though endogeneous digoxin-like raised against plant ouabain identified several subimmunoreactivity ( EDLI ) was also used to detect stances, some of which might be isomers of plant endogenous sodium transport inhibitors, there is much ouabain [6 ] . evidence that digoxin-like immunoreactivity is often Several groups have induced hypertension in the rat dissociated from digoxin-like biological activity. Indeed by long term administration of plant ouabain and in in a recent review Goto et al. [4] have deliberately rats immunized against plant ouabain the increase in omitted all reference to data obtained using this assay.
arterial pressure in the reduced renal mass salt loaded In 1991 Hamlyn and colleagues [5] obtained 31 mg rat and in the Dahl salt sensitive rat is diminished. of a pure Na-K-ATPase inhibitor from 300 l of human There is also a recent report by Goto of an ectopic corticotropin syndrome in a man with carcinoma of Correspondence and offprint requests to: H.E. de Wardener, the lung which gave rise to a mineralocorticoid type of hypertension [7] . Plasma and urinary levels of a Nephrol Dial Transplant ( 1997) 12: Editorial Comments 385 ouabain-like compound which was shown to coincide Na-K-ATPase in contrast to plant ouabain. Rat hypothalamic material inhibits renal and synaptosomal with plant ouabain on HPLC were markedly increased and correlated with the blood pressure before and after Na-K-ATPase with a potency~1000 times greater than plant ouabain. In addition, this increased potency the blood pressure had been lowered with chemotherapy of the tumour. The maximum concentration of appears to change with age for renal Na-K-ATPase obtained from an adult rat is more sensitive to the plasma ouabain-like substance was 3570 pmol. It is not certain whether when an increase in the plasma hypothalamic substance than is renal Na-K-ATPase from a young rat. In contrast the effect of plant level of ouabain is associated with hypertension the increase in pressure is due in part by a direct effect on ouabain is unaffected by the age of the rat from which the renal Na-K-ATPase is obtained. the arteries but plant ouabain at concentrations as low as 100 pmol can cause concentration and time dependHaupert's group have studied human plasma ouabain, bovine hypothalamic ouabain and plant ouabain ent impairment of acetyl choline-induced relaxation of human resistance arteries in vitro. And concentrations after derivatization of all three by naphthoylation [10 ] .
Surprisingly, the products of human plasma naphthoylof ouabain 100-10 000 pmol increase caffeine evoked contraction of rat mesenteric arteries, again in vitro [6 ] . ated ouabain and bovine hypothalamic naphthoylated ouabain have the same retention time but the retention time of the products of naphthoylated plant ouabain
Hypothalamic ouabain are longer. Accordingly the two animal substances are not plant ouabain, but they appear to be the same It is very likely that if an endogenous ouabain-like substance has an effect on the blood pressure it usually isomer of plant ouabain, in other words mammalian ouabain. The possibility that mammalian ouabain is does so via the hypothalamus [6 ] . Catecholaminergic denervation of the hypothalamus by an injection into an artifact, a product of isomerization of plant ouabain occurring during the isolation process was excluded by the third ventricle or an incision at the cephalic end of the third ventricle (the AV3V lesion) in the reduced submitting plant ouabain to the isolation, purification, naphthoylation protocol employed for the plasma and renal mass salt loaded rat and the DOCA salt loaded rat prevent the expected increase in both the arterial hypothalamic ouabain. HPLC and CD spectroscopy showed that no structural changes had taken place pressure and the plasma's capacity to inhibit Na-KATPase. The central administration of a dopamine thus eliminating mammalian ouabain from being an artifact of plant ouabain. These findings dispose of the receptor agonist, pergolyde, atrial natriuretic peptide and saline trigger the release of a circulating Na-K-fear that the endogenous ouabain-like material is a contaminant of exogenous plant ouabain and perhaps ATPase inhibitor. Plant ouabain instilled centrally increases the blood pressure and renal sympathetic explain some of the difficulties encountered when using antibodies raised against plant ouabain. nerve activity. And the intracerebroventricular preinjection of digoxin specific antibody Fab fragments prevents the increase in arterial pressure induced by References the central administration of hypertonic saline. There is also Takahashi and Sano's demonstration of Nonsteroidal anti-inflammatory drugs ( NSAIDs) and the kidney renal hemodynamics [4] [5] [6] . In this situation, a signicomprise a wide group of compounds that, despite ficant decline in renal function is almost inevitable, differences in their chemical structure, share a similar whereas overt acute renal failure associated with spectrum of pharmacological activities (antiNSAIDs is believed to account for~16% of cases of inflammatory, analgesic, antipyretic, anti-platelet), drug-induced acute renal failure [7, 8] . The populations side-effects (ulcerogenic and nephrotoxic), and mechat greatest risk for renal functional alterations from anism(s) of action. The latter is dependent, at least in NSAID therapy include patients with volume depletion part, upon inhibition of the cyclooxygenase activity of from any cause, chronic glomerulonephritis, agetwo isoenzymes, the prostaglandin (PG) endoperoxide related reduction of GFR, and atherosclerotic cardio-H synthase-1 (PGHS-1, also referred to as COX-1), vascular disease. Such conditions share either exaggerconstitutively expressed in most cells and tissues, and ated vasoconstrictory stimuli to the kidney, or a local the prostaglandin (PG) endoperoxide H synthase-2 reduction in the synthesis of vasodilator PGs. In this ( PGHS-2, also referred to as COX-2), expressed only setting NSAIDs may remove the modulatory action of in activated cells [1, 2] . The kidney is a rich source of PGs on vasoconstrictor agents, thereby inducing renal these two isozymes, which catalyze the conversion of functional alterations [4] . arachidonic acid to PG endoperoxide H 2 (PGH 2 ), NSAID administration may also be associated with ultimately leading to the production of PGs [3] .
salt retention, particularly during long-term treatment. Over the last 10-20 years, a number of experimental
The mechanism underlying this effect is likely to be as well as clinical studies has univocally attributed to related to decreased GFR and enhanced sodium reabPGs a crucial role in the regulation of many aspects sorption. The risk for clinically evident peripheral of renal function. This information has alerted clinical oedema is very low. It occurs in only 3-5% of patients nephrologists for the potential nephrotoxicity of chronically taking NSAIDs. Hyperkalaemia has been NSAIDs, thus contributing to the growing awareness reported in some cases, mainly associated with potasof renal complications by the use of this class of drugs.
sium-sparing diuretics and ACE inhibitors. NSAIDThe aim of this article is to provide an overview of induced sodium and potassium disturbances are readily the present understanding on NSAID-related renal reversible after drug discontinuation [9 ] . effects. Additionally, proper use of anti-inflammatory agents sparing renal PG synthesis will be addressed.
Finally, we shall discuss the potential safety of newly NSAIDs and structural renal alterations developed NSAIDs selective for PGHS-2, which catalyzes the production of PGs involved in inflammation, In addition to functional renal changes, NSAIDs may and devoid of inhibitory effect on PGHS-1 prostanoid cause nephrotoxic effects with mechanisms that are not synthesis, implicated in the regulation of renal clearly related to the inhibition of PG synthesis. Acute hemodynamics and water and sodium reabsorption.
interstitial nephritis, with and without minimal lesions in the glomeruli and heavy proteinuria, has been reported to occur with a variable incidence, ranging
NSAIDs and functional renal alterations between 0.01% and 2% of patients hospitalized for drug-induced acute renal failure. This complication An acute reduction of GFR and RBF ranging from may develop anytime from days to months after initi-20-50% to acute renal failure can occur within 24-48 h ation of treatment with NSAIDs, and, in contrast with of treatment with virtually all NSAIDs used at full the haemodynamic variety of acute renal failure, there anti-inflammatory dosage, and is usually reversible are not well documented risk factors. However, women upon drug withdrawal. The risk for these adverse renal and aged individuals seem to be more frequently effects is largely dose-dependent, and is negligible for involved. Spontaneous recovery follows discontinuhealthy individuals, whose renal hemodynamics is min-ation of the drug, resolution time varying from days imally dependent upon intact PG synthesis. In contrast, or weeks up to one year. Yet, a full renal recovery is not always the rule, and a permanent renal damage Correspondence and offprint requests to: Giulio Alberto Cinotti, may also occur [9, 10] . syndrome may occur as idiosyncratic reaction to vari-
Sulindac is believed to be a NSAID with effective anti-inflammatory activity associated with low nephroNSAIDs, the prompt and complete recovery after drug discontinuation, and the absence of recurrent disease toxicity. Its renal-sparing properties rely upon the presence in the kidney of oxidative enzymes able to may help to clinically distinguish NSAID-associated MN from the idiopathic form [11] .
rapidly convert the active metabolite of the drug, sulindac sulfide, to the inactive parent sulfoxide comChronic interstitial nephritis and papillary necrosis (analgesic nephropathy) may develop as a consequence pound, as well as to the inactive sulindac sulfone. Due to its unique metabolism, sulindac administration has of long-term abuse of a combination of analgesics, mostly those mixture containing phenacetin. Analgesic been reported to be safe, at least in short-term treatment, in situations at risk, such as chronic glomeruloabuse is a major cause of end-stage renal failure in Western countries. In Europe 2.5% of patients on nephritis, chronic renal failure, congestive heart failure, and cirrhosis with ascites [16 ] . On the other hand, the dialysis had analgesic nephropathy, 1-2% in United States and 12% in Australia. A partial recovery from long-term consequences of sulindac treatment in such patients still need to be defined, and caution should this nephropathy and/or stabilization of renal lesions may be obtained by withdrawal of the offending drug, be taken when prescribing sulindac for prolonged treatment. depending on the extent of renal damage [12] .
Acetaminophen has been reported to locally inhibit PG synthesis in the hypothalamus, where it exerts its NSAIDs and proteinuria antipyretic and analgesic effect. It is apparently devoid of inhibitory action on renal PG synthesis, and could therefore be the antipyretic/analgesic of choice in subBoth short-and long-term NSAIDs treatment, particularly indomethacin, has been reported to reduce pro-jects with underlying renal disease. Nevertheless, due to its potential for inducing analgesic nephropathy, its teinuria in patients with the nephrotic syndrome. The antiproteinuric effect of these drugs seems to be habitual consumption should be discouraged [9] . enhanced by sodium depletion. Experimental as well as clinical studies have shown that NSAIDs decrease
Selective inhibitors of PGHS-2
proteinuria by lessening GFR and RPF, and by directly ameliorating glomerular perm-selectivity to macromolecules. Thus, due to their effect on proteinuria as The vast majority of NSAIDs inhibits the activity of both PGHS-1 and 2. In the kidney, PGHS-1 is constituwell as on renal haemodynamics, NSAIDs should theoretically delay the progression of glomerular tively expressed in almost all cell lines, and likely catalyzes the synthesis of prostanoids involved in the damage. However, contrasting data have been reported in this regard, and at the present time it is difficult to maintenance of renal function. In contrast, PGHS-2 is induced in renal native as well as in renal infiltrating draw conclusions on possible long-term benefits [13] . Besides, one should keep in mind the risk of acute and cells by inflammatory stimuli. PGs produced by this enzyme are very likely involved in the cellular response permanent renal impairment, and the availability of safer antiproteinuric agents such as ACE inhibitors, to injury. Recently, attention has been focused on the development of NSAIDs selective toward PGHS-2 with the same effect as NSAIDs on glomerular permselectivity, but with opposite effects on renal and, thereby, effective in reducing renal inflammation without altering renal haemodynamics [2, 3] . Presently, haemodynamics.
there is only experimental evidence supporting such hypothesis [17 ] . Thus, clinical studies are clearly
Renal sparing NSAIDs
needed to define the therapeutic potential of this new class of NSAIDs. Despite the clinical usefulness of NSAIDs, the growing awareness of their nephrotoxic potential is presently Summary limiting their use. Thus, considerable efforts are being made to identify NSAIDs devoid of renal adverse side-effects.
In patients with PG-dependent renal function, NSAID administration constantly reduces GFR and RBF in a Low-dose aspirin selectively inhibits platelet prostanoid production without affecting renal PG syn-dose-dependent fashion. In this situation, the risk of overt acute renal failure is high and should be taken thesis. The mechanism is likely to be related to the different rate of recovery of PGH-synthase in the into proper account. In contrast, the incidence of NSAID-related renal structural alterations appears to kidney and in platelets, following irreversible acetylation of the enzyme, and possibly to a lesser be very low, yet the absolute number of patients may be significant considering the wide use of such drugs. sensitivity to aspirin of renal PGH-synthase. Due to its selectivity, to date low-dose aspirin represents a Concerning the antiproteinuric effect of NSAIDs, the unfavourable ratio risk/benefit does not seem to supdrug of choice for the prevention of thrombotic events, even for those patients with underlying renal disease, port their indication in proteinuric nephropathies. counter drug: is there a risk for renal injury? Clin Nephrol 1993;
The development of PGHS-2 selective inhibitors is 39: 1-6 promising, and may open new therapeutical strategies 9 . Whelton A. Renal effects of over-the-counter analgesic. J Clin in the treatment of the progression of renal disease. Pre-eclampsia is characterized by a triad of hyperten-dynamics occur before significant expansion of maternal plasma volume has taken place, but in close sion, proteinuria, and oedema which appears late in temporal relation with a decrease of systemic vascular the second trimester or in the third trimester of pregresistance [4 ] . Several hormones (prostacyclin, atrial nancy. This complication is seen in 5-10% of pregnannatriuretic peptide, nitric oxide) seem to be involved cies [1, 2] . Pre-eclampsia is the leading cause of in the pathomechanisms of these changes [5 ] . They maternal mortality and of perinatal mortality. may be involved in the genesis of glomerular hyperAlthough this condition has been known since filtration with subsequent increased urinary excretion antiquity, there are still gaps in our understanding of of creatinine (thus in pregnancy plasma creatinine is the pathophysiology of pre-eclampsia. Hypertension is always lower than 88 mmol/l ) and proteins (up to a foremost sign of pre-eclampsia, while blood pressure 200 mg/d) [1] . is determined by effective blood volume and vascular Pregnancy is characterized by plasma hypoosmolalresistance. Consequently the question arises to what ity (a decrease of plasma osmolality by approximately extent abnormalities in blood volume regulation are 10 mOsm/kg H 2 O), and a slight reduction in colloid involved in the pathogenesis of hypertension in pregosmotic pressure, plasma sodium, and potassium (as nant women with pre-eclampsia. compared with preconception values). Plasma hypoosDuring normal pregnancy an increase of kidney molality seems to be due to a resetting of the osmostat volume, GFR ( by 50% after 20 weeks of pregnancy) and thirst center. In pregnancy vasopressin is secreted and RBF ( by 60% after 20 weeks of pregnancy) is normally at osmolalities above the lowered threshold regularly observed [3, 4] . Changes in renal haemoand thirst is preceived at lower effective plasma osmolalities than in nonpregnant women. increases by 8.5 l, of which 6-6.5 l are located extracel-tions increase earlier and proportionally more than plasma renin activity. This constellation suggests that lularily and only 2 l intracellularily. From this 6.5 l located in the ECFV, 2 l is accounted for by foetus, factors other than renin are involved in the regulation of aldosterone secretion. As the RAA system responds amniotic fluid and placenta. During pregnancy plasma volume increases by~1200 ml (=40% of the precon-adequately to stimulation (upright position) and inhibition (salt load, water immersion), it seems likely that ception value), and erythrocyte mass by 420 ml [1] . Thus circulating blood volume increases by 1620 ml increased activity of this system in pregnancy is a secondary response to primary vasodilation or salt which is 30% above preconceptional values. As plasma volume increases proportionally more than the erythro-losing factors [8] . The reaction of the RAA system to stimulation suggests that stimulation of this system is cyte mass, haemodilution with a subsequent decrease in erythrocytes per volume unit are seen during normal submaxial, and that the circulation is underfilled during pregnancy. In the genesis of vasodilation nitric oxide pregnancy. During the last trimester the intravascular compartment increases proportionally more than the [13] , ANP [14] and prostacyclin [15] may play a role for the elevated activity of the RAA system in extravascular compartment of the ECFV [6 ] . Expansion of the ECFV during pregnancy is associated pregnancy, but other factors, particularly hormones produced by the placenta e.g. progesterone may also with sodium retention of~900 mmol at the end of pregnancy. The question arises: How is such sodium be involved.
Contrary to what may be expected from physiologiretention accomplished.
As this sodium retention occurs during intake of cal experiments [16 ] plasma ANP concentrations (in the third trimester) are similar [14 ] to preconception variable amounts of sodium, it follows, that the kidneys are able to adapt to large changes of dietary salt values [11, 17] but elevated in early pregnancy [14 ] .
When related to the increased intravascular volume intake, and that both, during administration of large amounts of sodium and sodium restriction, respect-plasma ANP levels are slightly elevated even in the third trimester of pregnancy. In addition ANP secreively, net accumulation of sodium takes place [7 ] . Although the increase of plasma volume begins already tion in late pregnancy is responsive to physiologic stimuli such as central hypervolaemia evoked by water in early pregnancy, it seems likely, that this increase is due not only to a net positive sodium balance, but immersion [11 ] . As ANP antagonizes vasoconstriction, it may contribute to the systemic vasodilation during also to redistribution of body fluids. As during the second and third trimester of pregnancy the increase pregnancy [14 ] . ANP inhibits aldosterone synthesis in the adrenal glands, shifts fluid from the vascular to of the ECFV is relatively larger than of total fluid, it seems likely, that redistribution of fluid from the the interstitial compartment and increases sodium excretion by the kidney [16 ] . Therefore its role in intracellular to the extracellular fluid space is also taking place. In addition in these stages of pregnancy blood pressure and volume control during pregnancy, a state of sodium retention and hypervolaemia, a greater proportion of extracellular fluid is located intravascularly, than in the interstitial space. Such remains unclear.
In which way does pre-eclampsia differ from normal redistribution of ECFV is favoring perfusion of maternal organs especially of the placenta [6 ] . As capillary pregnancy? Pre-eclampsia is characterized by reduction of renal blood flow and glomerular filtration rate, permeability remains unchanged during normal pregnancy, the pathomechanism of increased intravascular absolute reduction of plasma volume by~600 ml, and reduced cardiac output [12, 17] . Women with severe volume, in spite of a lower plasma colloid osmotic pressure during pregnancy, remains to be clarified. pre-eclampsia retain more sodium after a saline load, probably because of volume contraction and decreased Vasodilation and lowered vascular resistance appear in the early stage of pregnancy and seem to be involved glomerular filtered load of sodium [17] . In normal pregnancy one observes refractoriness to the pressor in this phenomenon [8 ] . In spite of an increased plasma volume, the maternal circulation seems to be action of angiotensin II, such refractoriness is lost [18, 19] in pre-eclampsia. Although total sodium and underfilled. Elevated plasma renin activity and plasma aldosterone level can be interpreted as homeostatic water retention in pre-eclampsia is of the same magnitude or even greater than in normal pregnancy, plasma adaptations to underfilling [9] [10] [11] . Plasma atrial natriuretic peptide (ANP) concentration is normal [11 ] volume is contracted. This finding suggests a proportionally greater increase of the interstitial fluid space (under physiological conditions hypervolaemia would suppress the renin-angiotensin-aldosterone system and than of the vascular compartment. Redistribution seems to be due to increased capillary permeability stimulate ANP secretion).
By which mechanism are changes in intravascular [20] . In view of diminished renal excretion of sodium and extravascular, extracellular volumes accomplished?
As vascular resistance decreases early in pregnancy, after a saline load, one would expect alterations in secretion of volume related hormones. In fact lower, it is likely that vasodilation is the most important trigger for sodium retention by the kidneys in preg-normal or only moderately elevated levels of plasma renin, and aldosterone are present in pre-eclampsia nancy. The activity of the RAA system is increased during pregnancy [9, 11] , although no clear-out relation which are still reactive both to stimulatory (upright position [17 ] ) and inhibitory stimuli (e.g. central hyperexists between plasma aldosterone levels and plasma renin activity [9] [10] [11] [12] . Plasma aldosterone concentra-volaemia [9] [10] [11] ). In addition in pre-eclampsia the dissociation of the physiological relationship between Ischaemia of the uteroplacental unit seems to be the central event. renin and aldosterone secretion is more pronounced than in normal pregnancy (in pre-eclampsia the plasma Although recently knowledge of the pathophysiology of pre-eclampsia progressed markedly, better insight aldosterone: renin ratio is twice that of normal pregnant women [6 ] .
into pathomechanisms did have no impact on prevention or therapy of this syndrome. Treatment The cause of lower plasma renin and aldosterone concentrations in pre-eclamptic women is not clear. of endothelial dysfunction may well be required.
Administration of endothelin antagonists, inhibitors of Prostacyclin synthesis is reduced in pre-eclampsia [12, 15] and prostacyclin is a stimulator of renin secre-the metalloendopeptidase E3,4,11,24 (this enzyme is inactivating ANP), blockers of ANP clearance reception. It is likely that prostacyclin is involved in the reduction of renin secretion in pre-eclampsia.
tors, promotors of NO, adrenomedullin or prostacyclin synthesis are on the horizon, but whether they will ANP plasma levels in pre-eclamptic women do not differ from those found in normal pregnancy [10, 11] improve the management of pre-eclampsia remains to be elucidated. although elevated concentrations were also reported [21 ] . Increase of central volemia induced by water immersion [11] or prolonged lateral recumbency [21 ] References is followed by an increase of plasma ANP level which is less marked than in normal pregnancy [11] . From 
Introduction
MDRD study [4] were all well trained to adjust and monitor protein intake of the patients (whose nutriThe effects of dietary protein on renal function were tional education in terms of discriminating the protein recognized as early as half a century ago. The issue content of food items was started in the run in period!). has recently resurged. The past years have seen a
The non-compliant patients were 'monitored, tracked, debate raging between those nephrologists who claim and counselled by means of telephone calls and addithat the effect of low protein diets on slowing progrestional visits' [10] . However, as low protein diets are sion of chronic renal insufficiency (CRI ) is limited becoming increasingly used in every day clinical prac- [1] [2] [3] [4] [5] [6] according to the results of large-scale intentiontice, the picture of compliance may be less rosy [5 ] , to-treat trials [1] [2] [3] [4] , and those who claim that the and this will limit the possibility of slowing progression effect is limited only because compliance is less than of CRI safely in such patients [10] . optimal [7] [8] [9] [10] . This debate is not purely academic.
Therefore, the two key questions remain as to how Its impact goes beyond the fate of the individual compliance can be improved (i) without adversely patient with CRI, since a lot of money may be saved affecting the nutritional status, and (ii) while preserving to the community by postponing the need for dialysis.
the potential to slow progression of CRI and postponIf one accepts the hypothesis that reduction of ing the need for dialysis. protein intake slows progression of CRI in experimental animals and humans, the logical question arises whether and to what extent protein intake can be Are all proteins created equal?
safely reduced without adversely affecting the nutritional status or patient compliance.
In attempting to solve these problems, research efforts must focus not only on the clinical effects of reducing the quantity of protein intake, but also of modifying
Is dietary protein restriction effective and safe?
its quality. This area has not yet been sufficiently investigated, but a considerable body of evidence sugAlmost all clinical trials have shown that it is not easy gests that not only the quantity, but also the type of to lower protein intake to less than 0.8 g/kg of ideal protein ingested may influence their effects on renal body weight over extended periods of time. One should haemodynamics. It is well known that vegetarians have remember that the duration of the pre-dialytic period a lower glomerular filtration rate than omnivores [11 ] . of CRI may be as long as 10-20 years in some patients. This finding is not easy to interpret, however. Not Today nobody knows the level of compliance nor the only is the average protein intake lower in vegetarians, long-term consequences of strict protein restriction. but the diet is also different in other important respects. The published trials are reassuring in this respect, but Moreover, it is important to remember that the amount not sufficient, because they involved only a 2-4 year of amino acids present in different diets may not reflect follow-up. In this context I would like to stress that the quantity or pattern absorbed, i.e. their bioavailability. Williams et al. [12] compared the effects of two showed that subtotally nephrectomized animals which the simple reduction in protein intake. This idea is also supported by the fact that uraemic patients tend to were kept on soya diets had lower glomerular filtration rate and effective renal plasma flow, higher renal spontaneously reduce their protein intake because of anorexia. vascular resistance, less proteinuria, renal hypertrophy and histological damage, and longer survival than those on casein diets. No differences between the diet What we don't know, but should know were found with respect to growth rates despite the fact that the renal weight of the animals kept on soya However, many points deserve further clarification. diets was significantly lower than that of the animals First of all, how much time can be gained in postponing on casein diets. Differences in the amino acid composi-dialysis by restricting, or even better, modifying protein tion of the diets may have had an effect on the intake? From a clinical point of view, the time gained deterioration of renal function: cationic amino acids is unlikely to be very significant, because on the basis may block the anionic sites of the glomerular basal of intention-to-treat analysis no major effect was membrane and cause proteinuria by disrupting the detected in four randomized clinical trials involving electrostatic barrier. When a vegetable protein diet is hundreds of patients [1] [2] [3] [4] . Nevertheless, according to given the reduction in the fractional clearance of a recent meta-analysis [15] , restricted intake of dietary plasma proteins suggests that vegetable proteins do proteins apparently slows progression of diabetic and not only affect glomerular haemodynamics, but also non-diabetic nephropathy. Furthermore, secondary renal handling of proteins [13] .
analysis of the result of the MDRD study [10 ] suggests that a reduction in total protein intake (including food and supplement) by 0.2 g/kg/day was associated
What are the renal effects of vegetable proteins in with a slowing of the mean decline in GFR by humans?
1.15 ml/min/year, i.e. by 29%. This would translate into a 41% prolongation of the time to reach end-stage It is important from a clinical point of view that renal failure. ingestion of vegetable proteins (regardless of their Of course, no data are yet available concerning the quantity) lowers glomerular filtration rate, renal long-term effects of a vegetable protein diet. The plasma flow and fractional clearances of albumin and renoprotective effect of ACE-inhibition has very IgG in humans compared with the ingestion of animal recently been demonstrated in patients with CRI of proteins. The effect is seen even after short periods of various etiologies. A 53% reduction in the risk observation [13] . Thus not all proteins are equal in of progressive renal insufficiency was noted [16 ] . terms of their renal effects. These differences may be Obviously it is easier to obtain and maintain lower partially related to differences in secretion of glucagon blood pressure with ACE-inhibitors than to impose and renal vasodilatory prostaglandins [14 ] . The demanding dietary restrictions. response of glucagon and renal vasodilatory prostaAnother point that needs to be clarified is the glandins after a soya meal is blunted compared to the interaction between ACE-inhibition and the total ingestion of a meat meal.
amount of protein intake. On the basis of available data [16 ] the effects are not additive in terms of slowing progression of CRI, although an additive effect on
Protein intake versus ketoacid/aminoacid reduction of proteinuria has been documented [17] .
supplements
No data are yet available concerning the effects of vegetable protein on progression of CRI at various A very recent secondary analysis of the MDRD study blood pressure levels. Further, unresolved questions suggests that the trend towards a benefit from the very include the following: Are all vegetable proteins equal low diet observed in the intention-to-treat analysis was in their renal effects? And what is their long-term due more to the lower protein intake (from food and nutritional effect in patients with CRI? supplement) than the prescription of the very low diet I emphasize that all patients with CRI must arrive with the ketoacid-aminoacid supplement [10 ] . These at the stage of renal replacement therapy (including authors also examined the effect of the supplement renal transplantation) in as healthy a condition as regardless of achieved protein intake and found that-possible. It is ethically unacceptable to delay the start for a fixed level of protein intake from food only-the of renal replacement therapy if the patient risks malnuassignment to the very low protein intake group was trition [18 ] . It is estimated that up to 10% of patients associated with an 86% increase in the risk of renal with CRI are malnourished at the start of dialysis. failure or death at any given point in time. This Malnutrition is related to shorter survival in dialyzed observation is consistent with a detrimental effect of patients [19 ] . the amino acid component of the keto acid/amino acid supplement.
Conclusion
The results of this study thus suggest that lower intake of protein but not of supplement may play a role in slowing progression of CRI. This observation I conclude that the therapeutic approach of prescribing a vegetable protein diet is fascinating and promising points to the importance of looking for alternatives to Nephrol Dial Transplant ( 1997) [20 ] . I caution, however, that the above points must dietary protein restriction on the progression of advanced renal be clarified before such diets are recommended indis- alterations in cytokine release in vitro, and hence Potential approaches to improve compatibility of impairment of peritoneal immunocompetancy in vivo the dialysate when exposed to an infective agent [4, 5] . This has been shown to be influenced both by the acidic pH, Clinical trials comparing a bicarbonate-buffered 'twinhigh glucose, and high osmolality of the solutions. bag' dialysate with lactate-buffered dialysate are curWhen considering peritoneal fibrosis in the absence of rently taking place. As the bicarbonate dialysate has a infection there is strong evidence that the same non-normal or slightly alkaline pH and contains no lactate, physiological features of dialysate influences mesothel-the expectation is that biocompatibility will improve. ial cell injury and fibrosis directly. In addition evidence Amino-acid-containing dialysate as now available comsuggests that the high glucose concentration is a major mercially, and advocated for its potentially beneficial aetiological factor. High concentrations of glucose are effects on nutrition. In vitro studies, however, are known to suppress mesothelial proliferation and conflicting as to whether they have beneficial effects protein synthesis [6 ] , possibly through increased TGF-on mesothelial cell proliferation [21] or have no differb gene expression [7 ] , which has independently been ent an effect from glucose-based dialysate [22] . Aminoshown to suppress mesothelial cell growth and regen-acid dialysate may induce less mesothelial cell collagen eration [8 ] .
synthesis than glucose-based dialysate [21 ] , but it may Human mesothelial cells produce the extracellular render the cells more susceptible to damage by free matrix proteins fibronectin, laminin and collagen types radicals [23] . Theoretical concerns over worsening I and III [9] . In cultured human mesothelial cells an metabolic acidosis from this dialysate formulation increasing glucose concentration provokes an increase appear unfounded in clinical trials, although serum in both the amount of fibronectin and its messenger urea does rise [24] . Icodextrin has been recently RNA [10 ] . This effect appears to be directly related to launched, and has been shown to be safe and effective glucose concentration and unrelated to increasing if used to replace high concentration (3.86%) glucose osmolality [6 ] . The production of extracellular matrix dialysate for an overnight dwell [25] . In vitro it appears protein by mesothelial cells is stimulated by that Icodextrin is less inhibitory to granulocyte and interleukin-1 ( IL-1) [11] , as is the production of monocyte function, but is little different in its effect on TGF-b [12 ] . IL-1 was previously shown to be produced mesothelial cell viability compared with glucose by stimulated macrophages and by mesothelial cells dialysate [26 ] . However, as with glucose dialysate it themselves [13] .
less inhibitory if corrected to a physiological pH [4 ] . Certain aspects of dialysis with concentrated glucose solutions may produce cell damage by other mechanConclusions isms. Peritoneal dialysis solutions are heat sterilized and heat sterilization of commercial glucose-based peritoneal dialysis solutions has been shown to inhibit In summary, failure of the peritoneal semipermiable growth of an in vitro cell culture even when corrected membrane cannot be attributed to a single aetiological for low pH [14 ] , and has been the subject of a previous factor. However, the high glucose concentration and editorial [15] . In diabetic patients glucose is known to the combination of low pH and high lactate concentraform abnormal complexes with tissue proteins [16 ] . tion of standard peritoneal dialysis solution are Similarly the high glucose concentration in the periton-important factors in progressive peritoneal membrane eal cavity during CAPD results in the complexing of dysfunction. High glucose concentration has been glucose with soluble and structural proteins within the shown to impair cytokine release and cellular immunperitoneum. Glucose-containing peritoneal dialysis ity, increase production of extracellular matrix profluid at the end of a standard dwell and depleted of teins, and inhibit cellular proliferation through a patient albumin, has been shown to be capable of variety of different mechanisms. Early studies of noncomplexing with supplemented human albumin to form glucose-containing peritoneal dialysis solutions suggest both glycated albumin and advanced glycation end-that they may cause less disruption of cellular mediproducts (AGE ) [17] . In diabetes these AGE are ators [4 ] , and longer-term clinical trials are awaited implicated in vascular basement membrane thickening, with increasing interest. and could therefore be implicated in peritoneal baseHaving used glucose-based peritoneal dialysis solument membrane thickening, and progressive peritoneal tions for 20 years, is it now time to choose a better membrane failure. In addition, exposure to glycated alternative? albumin in vitro has also been shown to be directly inhibitory to mesothelial growth and regeneration [18] . References Initial studies that exposed confluent peritoneal mesothelial cells to unaltered dialysate for prolonged [19 ] . Subsequent studies using lactate dehydrogenase that it is the combination of low pH and high lactate Nephrol Dial Transplant 1995; 10: 1905-1911 concentration that appears to be toxic to the cultured mesothelial cell [20 ] .
Windhager EE, (ed. it increases the angiotensin II receptor density [46 ] . with CsA [48] and that these agents will not reduce during the first 9 days of cyclosporin therapy in males.
blood pressure sufficiently. However, this view is dubi- 
